Health Economics

NICE rules 4 kidney cancer drugs not effective enough for NHS coverage, raising concerns about cost-effectiveness and patient access.

Learn about the possible change in attitude toward the role of pharma in providing healthcare information in Europe.

Introduction to the FDA's “E2F Development Safety Update Report,” guidelines (draft form), describing the format, content, and timing of a DSUR.

Discover how Hal Rosenbluth, co-found of Take Care Health Systems, used his business expertise to bring comprehensive healthcare services to the workplace

Uncovering how Canada Heath Infoway plans to move from paper to electronic patient healthcare records.

Discussing the importance of capturing the comprehensive value of pharmaceutical products from a societal perspective

Discover the four issues that will influence the relationship between patients and their doctors, with Michael Wilks, Chairman of the CPME.

Uncovering the Complexities of Healthcare: Exploring the Moral, Economic, and Practical Implications of Providing Universal Healthcare Coverage

Summary of key topics and progress observed at the World Healthcare Congress in Berlin, focusing on electronic patient records and chronic disease management.

A balanced look at the impact of DTC advertising in healthcare

An analysis of the FDA's perceived failings, potential remedies, and suggestions for balancing public interest with private enterprise

Explore educational opportunities in health economics and outcomes research, including university programmes, e-learning courses, and organisations

Health Economics and Developments

This article highlights the need for health economists to be aware of international guidelines due to globalisation and introduces the "Pharmacoeconomic Guidelines Around the World" resource by ISPOR.

The role and significance of outcomes research in healthcare